Duyk said the $30 million in funding has helped Grove Biopharma expand from "about four people working on this" to a current ...

Roche said it will expand existing sites and construct new U.S. manufacturing and R&D infrastructure in areas such as gene ...

The investment would go toward high-tech research and development sites and new manufacturing facilities in Indiana, ...

Roche will invest $50 billion over the next five years for new research and development sites across the US, including a new manufacturing facility in Indiana.

NEWS: Roche is committing $50 billion over the next five years for new research and development sites across the country, and ...

INDIANAPOLIS — Roche, a Swiss biotechnology company whose U.S. headquarters is in Indianapolis, has announced its intention ...

In an hour-long meeting at Eli Lilly and Company’s headquarters in Indianapolis on April 15, the pharmaceutical company’s top ...

It was the second straight sizable increase, suggesting that U.S. drug makers with Irish manufacturing hubs like Indianapolis ...

Many major Indian pharmaceutical companies, including Dr Reddy's, Sun Pharma, and Aurobindo, derive 40-45% of their revenues from the US market, making them particularly vulnerable to any adverse ...

For instance, if tariffs are applied at a fixed rate across all the countries, Indian pharma companies could have an edge because of their cost advantage. India accounts for about 50% of generics ...